| Name | Walgreens #07656 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1199 Highway 49 S, Richland, Mississippi 39218 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (601) 932-3818 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
New research has opened up the prospect that gossypol – a drug refined from cottonseed oil and previously tried and abandoned as a male contraceptive – could boost the effectiveness of treatment for prostate tumours and possibly other common cancers as well.
EntreMed, Inc., a clinical-stage biopharmaceutical company developing therapeutic candidates primarily for the treatment of cancer, today reported that three months following administration with ENMD 0996, preclinical animal models showed inhibition of metastases. Data presented demonstrated that ENMD 0996 specifically blocks the activity of basic fibroblast growth factor (FGF-2), a naturally-occurring protein that stimulates angiogenesis, but had no effect on other angiogenesis stimulators.
A molecule thought to play a key role in some inflammatory diseases can be switched off by two widely used medicines, new research has shown.
Although traditionally understood to induce death in cancer cells, researchers at The University of Texas MD Anderson Cancer Center have discovered that the DAPK1 protein is actually essential for growth in breast and other cancers with mutations in the TP53 gene. This discovery indicates DAPK1 may be a promising new therapeutic target for many of the most aggressive cancers.
› Verified 3 days ago
| NPI Number | 1023023264 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #07656 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1199 Highway 49 S, Richland, MS 39218 |
| Phone Number | 601-932-3818 |
News Archive
New research has opened up the prospect that gossypol – a drug refined from cottonseed oil and previously tried and abandoned as a male contraceptive – could boost the effectiveness of treatment for prostate tumours and possibly other common cancers as well.
EntreMed, Inc., a clinical-stage biopharmaceutical company developing therapeutic candidates primarily for the treatment of cancer, today reported that three months following administration with ENMD 0996, preclinical animal models showed inhibition of metastases. Data presented demonstrated that ENMD 0996 specifically blocks the activity of basic fibroblast growth factor (FGF-2), a naturally-occurring protein that stimulates angiogenesis, but had no effect on other angiogenesis stimulators.
A molecule thought to play a key role in some inflammatory diseases can be switched off by two widely used medicines, new research has shown.
Although traditionally understood to induce death in cancer cells, researchers at The University of Texas MD Anderson Cancer Center have discovered that the DAPK1 protein is actually essential for growth in breast and other cancers with mutations in the TP53 gene. This discovery indicates DAPK1 may be a promising new therapeutic target for many of the most aggressive cancers.
› Verified 3 days ago
News Archive
New research has opened up the prospect that gossypol – a drug refined from cottonseed oil and previously tried and abandoned as a male contraceptive – could boost the effectiveness of treatment for prostate tumours and possibly other common cancers as well.
EntreMed, Inc., a clinical-stage biopharmaceutical company developing therapeutic candidates primarily for the treatment of cancer, today reported that three months following administration with ENMD 0996, preclinical animal models showed inhibition of metastases. Data presented demonstrated that ENMD 0996 specifically blocks the activity of basic fibroblast growth factor (FGF-2), a naturally-occurring protein that stimulates angiogenesis, but had no effect on other angiogenesis stimulators.
A molecule thought to play a key role in some inflammatory diseases can be switched off by two widely used medicines, new research has shown.
Although traditionally understood to induce death in cancer cells, researchers at The University of Texas MD Anderson Cancer Center have discovered that the DAPK1 protein is actually essential for growth in breast and other cancers with mutations in the TP53 gene. This discovery indicates DAPK1 may be a promising new therapeutic target for many of the most aggressive cancers.
› Verified 3 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 181 Davis Johnson Dr D, Richland, Mississippi 39218 Phone: (601) 362-0523 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 199 Interstate Dr, Richland, Mississippi 39218 Phone: (601) 503-1553 | |
Cvs Pharmacy #05878 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 915 Us Hwy 49 S, Richland, Mississippi 39218 Phone: (601) 939-3970 | |
Walgreens #07656 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1199 Highway 49 S, Richland, Mississippi 39218 Phone: (601) 932-3818 | |
Kroger Pharmacy 449 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1167 Highway 49 S, Richland, Mississippi 39218 Phone: (601) 664-0600 |